MannKind Corporation
MNKDNASDAQHealthcare● Active
$3.39
$-0.01(-0.29%)
Market Cap$1.0B
P/E Ratio—
52W High$6.51
52W Low$2.23
MannKind Corporation (MNKD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MNKD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$0.05
Est. -$0.02 · -150.0%
Revenue
$0.09B
Est. $0.11B · -14.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
MNKD reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.02 | — | — | — | $0.11B | — |
| ▼ Q2 FY2026 | May 6, 2026 | -$0.02 | -$0.05 | -150.0% | $0.09B | $0.11B | -14.4% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.01 | -$0.05 | -400.0% | $0.11B | $0.10B | +14.7% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.01 | $0.03 | +200.0% | $0.08B | $0.10B | -17.8% |
| ▼ Q3 FY2025 | Aug 6, 2025 | $0.04 | $0.00 | -94.7% | $0.08B | $0.08B | -4.5% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.03 | $0.04 | +33.3% | $0.08B | $0.08B | -0.1% |
| — Q1 FY2025 | Feb 26, 2025 | $0.03 | $0.03 | +0.0% | $0.08B | $0.07B | +2.4% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $0.06 | $0.04 | -33.3% | $0.07B | $0.07B | -6.4% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
-$0.05
EPS Est.
-$0.02
EPS Surpr.
-150.0%
Revenue
$0.09B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.05
EPS Est.
-$0.01
EPS Surpr.
-400.0%
Revenue
$0.11B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.03
EPS Est.
$0.01
EPS Surpr.
+200.0%
Revenue
$0.08B
Q3 FY2025
Aug 6, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.04
EPS Surpr.
-94.7%
Revenue
$0.08B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.04
EPS Est.
$0.03
EPS Surpr.
+33.3%
Revenue
$0.08B
Q1 FY2025
Feb 26, 2025
EPS Actual
$0.03
EPS Est.
$0.03
EPS Surpr.
+0.0%
Revenue
$0.08B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.04
EPS Est.
$0.06
EPS Surpr.
-33.3%
Revenue
$0.07B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.23 | $0.25 | $0.26 | 1 |
| Q2 FY2028 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2028 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2027 | $0.06 | $0.06 | $0.06 | 1 |
| Q3 FY2027 | $0.16 | $0.17 | $0.18 | 1 |
| Q2 FY2027 | $0.14 | $0.15 | $0.16 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.2B | $0.2B | $0.3B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.2B | $0.2B | 2 |
| Q3 FY2027 | $0.1B | $0.2B | $0.2B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -150.0% | $2.86 | $3.56 | +24.48% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -400.0% | $3.50 | $3.24 | -7.43% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +200.0% | $5.48 | $6.06 | +10.58% |
| ▼ Q3 FY2025 | Aug 6, 2025 | -94.7% | $3.99 | $3.47 | -13.03% |
| ▲ Q2 FY2025 | May 8, 2025 | +33.3% | $4.85 | $4.63 | -4.54% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +0.0% | $5.65 | $5.47 | -3.19% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -33.3% | $7.44 | $7.39 | -0.67% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +249.9% | $5.27 | $5.01 | -4.93% |
Q2 FY2026+24.48%
Report Date
May 6, 2026
EPS Beat/Miss
-150.0%
Price Before
$2.86
Price After
$3.56
Q1 FY2026-7.43%
Report Date
Feb 26, 2026
EPS Beat/Miss
-400.0%
Price Before
$3.50
Price After
$3.24
Q4 FY2025+10.58%
Report Date
Nov 5, 2025
EPS Beat/Miss
+200.0%
Price Before
$5.48
Price After
$6.06
Q3 FY2025-13.03%
Report Date
Aug 6, 2025
EPS Beat/Miss
-94.7%
Price Before
$3.99
Price After
$3.47
Q2 FY2025-4.54%
Report Date
May 8, 2025
EPS Beat/Miss
+33.3%
Price Before
$4.85
Price After
$4.63
Q1 FY2025-3.19%
Report Date
Feb 26, 2025
EPS Beat/Miss
+0.0%
Price Before
$5.65
Price After
$5.47
Q4 FY2024-0.67%
Report Date
Nov 7, 2024
EPS Beat/Miss
-33.3%
Price Before
$7.44
Price After
$7.39
Q3 FY2024-4.93%
Report Date
Aug 7, 2024
EPS Beat/Miss
+249.9%
Price Before
$5.27
Price After
$5.01
Avg Beat Reaction-0.52%
Avg Miss Reaction+0.84%
Beat Rate4 / 8 quarters
Largest Move+24.48% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MNKD ends December
MannKind Corporation (MNKD) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-0.05 — missing the analyst consensus of $-0.02 by -150.0%. The next MNKD earnings date is expected around September 1, 2026.
Each quarter, investors track MNKD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MNKD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MNKD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MNKD earnings · 5 questionsMannKind Corporation's next earnings report is expected around September 1, 2026. MNKD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MNKD historically reports after market close (AMC).
MNKD earnings datewhen is MNKD earningsMNKD next earnings datewhen does MNKD report earningsMNKD earnings calendar
▸ Source: FMP · MannKind Corporation SEC filings · US GAAP · MannKind Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026